# US 6,726,898 B2 · Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,898 B2
- Document ID: US6726898B2
- Status: Granted
- Kind: B2
- Application number: 10/456,696
- Filed: 2003-06-06
- Published: 2003-11-27
- Granted: 2004-04-27
- Earliest claimed: 2000-11-17
- Inventors: Gary R. Jernberg
- Web page: https://patentgrep.com/patent/US6726898B2

## CPC

- A61K 8/02: characterised by special physical form
- A61K 38/1709: {from mammals}
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to compositions and methods of treating periodontal disease and related disorders utilizing a sustained, controlled release targeted delivery method to effectively disrupt and inhibit bacterial biofilms at periodontal treatment sites.

## Claims

### Claim 1

A method of delivering an agent that disrupts biofilm to a localized site in the mouth comprising:
inserting into a periodontal pocket a composition comprising the agent that disrupts biofilm;
the agent that disrupts biofilm being contained within a biodegradable microparticle;
the agent that disrupts biofilm being a furanone biofilm disrupter.

### Claim 2 (depends on 1)

The method of claim 1, wherein the furanone biofilm disrupter has Formula 1, 2, 3, 4, or 5:
wherein: R1-R2, are independently H, C1-C4 alkyl group, OH, NH2, SH, or halogen; R22 and R23 are independently H, S, O, NR, or NH); R24-R28 are independently H or halogen; and X, X1, and X2 are independently O, S, H2, or any combination of H plus one halogen or two halogens when one or more R groups is substituted;
wherein, R1, R2 and R3 are independently hydrogen, hydroxyl, alkyl containing from 1 to 10 carbon atoms, ether containing from 1 to 10 carbon atoms, ester containing from 1 to 10 carbon atoms, or halogenated alkene containing from 1 to 10 carbon atoms; or R2 and R3 together are unsubstituted or halogenated alkene containing from 1 to 10 carbon atoms and R4 is hydrogen or halogen;
wherein, R1 is hydrogen, hydroxyl, acetoxy, ester or ether; R2 is Br or H; R3 and R4 are independently hydrogen or halogen; and R5 is C1, C3, C5, or C11 alkyl; or
wherein, R1, R2, R3 and R4 are each independently hydrogen, halogen, hydroxyl, methyl, alkyl, ether or ester.

### Claim 3 (depends on 1)

The method of claim 1, wherein the microparticles degrade and release the agent that disrupts biofilm in a controlled, sustained manner.

### Claim 4 (depends on 1)

The method of claim 1, wherein the biodegradable microparticles comprise microspheres of diameter between 10 and 700 microns.

### Claim 5

A method of delivering an agent that disrupts biofilm to a localized site in the mouth comprising:
inserting into a periodontal pocket a composition comprising the agent that disrupts biofilm;
the agent that disrupts biofilm being contained within a biodegradable microparticle;
the agent that disrupts biofilm being an inhibitor of autoinducer-2; an agent that inhibits or disrupts the glycocalyx matrix of the bacterial biofilm; iron saturated lactoferrin; or a gingipain inhibitor.

### Claim 6 (depends on 5)

The method of claim 5, wherein the agent is a gingipain inhibitor designated in the scientific literature as DX-9065a.

### Claim 7 (depends on 5)

The method of claim 5, wherein the microparticles degrade and release the agent that disrupts biofilm in a controlled, sustained manner.

### Claim 8 (depends on 5)

The method of claim 5, wherein the biodegradable microparticles comprise microspheres of diameter between 10 and 700 microns.
